Introduction
Part I - Basic Requirements for Medicinal Products
• Chapter 1 Pharmaceutical Quality System (66 KB)(Deadline for coming into operation: 31 January 2013)
Chapter 1 Quality Management (revision February 2008) (29 KB)
• Chapter 2 Personnel (20 KB)
• Chapter 3 Premise and Equipment (34 KB)
• Chapter 4 Documentation (Revision January 2011) - Coming into operation by 30 June 2011 (33 KB)NEW
• Chapter 5 Production (50 KB)
• Chapter 6 Quality Control (33 KB)
• Chapter 7 on Outsourced activities (21 KB) (Deadline for coming into operation: 31 January 2013)
Chapter 7 Contract Manufacture and Analysis (22 KB)
• Chapter 8 Complaints and Product Recall (18 KB)
• Chapter 9 Self Inspection (11 KB)
Part II - Basic Requirements for Active Substances used as Starting Materials
• Basic requirements for active substances used as starting materials (452 KB)
Part III - GMP related documents
• Site Master File (33 KB)
• Q9 Quality Risk Management
• Q10 Note for Guidance on Pharmaceutical Quality System
• MRA Batch Certificate (101 KB)
• Template for the 'written confirmation' for active substances exported to the European Union for medicinal products for human use (40 KB)
Annexes
Table Eudralex
Annex 1 Manufacture of Sterile Medicinal Products (122 KB)
Annex 2 Manufacture of Biological active substances and Medicinal Products for Human Use (171 KB) (Deadline for coming into operation: 31 January 2013)
Manufacture of Biological Medicinal Products for Human Use (30 KB)
Annex 3 Manufacture of Radiopharmaceuticals (68 KB)
Annex 4 Manufacture of Veterinary Medicinal Products other than Immunological Veterinary Medicinal Products (14 KB)
Annex 5 Manufacture of Immunological Veterinary Medicinal Products (43 KB)
Annex 6 Manufacture of Medicinal Gases (48 KB)
Annex 7 Manufacture of Herbal Medicinal Products (23 KB)
Annex 8 Sampling of Starting and Packaging Materials (20 KB)
Annex 9 Manufacture of Liquids, Creams and Ointments (13 KB)
Annex 10 Manufacture of Pressurised Metered Dose Aerosol Preparations for Inhalation (17 KB)
Annex 11 Computerised Systems (revision January 2011) (22 KB)
Annex 12 Use of Ionising Radiation in the Manufacture of Medicinal Products (50 KB)
Annex 13 Manufacture of Investigational Medicinal Products (67 KB)
Annex 14 Manufacture of Products derived from Human Blood or Human Plasma (50 KB) - May 2011
Annex 15 Qualification and validation (136 KB)
Annex 16 Certification by a Qualified person and Batch Release (41 KB)
Annex 17 Parametric Release (124 KB)
Annex 19 Reference and Retention Samples (24 KB)
Glossary
• Glossary (27 KB)
Other documents related to GMP
• Compilation of Community Procedures on Inspections and Exchange of Information updated to include new EU formats and procedures
• Guidelines on Good Distribution Practice of Medicinal Products for Human Use (94/C 63/03) (94 KB)